Selected article for: "accuracy sensitivity and load detection"

Author: Cobo, Fernando
Title: Application of Molecular Diagnostic Techniques for Viral Testing
  • Document date: 2012_11_30
  • ID: jiy4cp4n_99
    Snippet: Molecular techniques can be very useful for the diagnosis of viral hepatitis infections such as hepatitis A, B, C, D and E in cases in which serological assays are no conclusive. However, currently the main application of nucleic acid test in the management of these viruses, above all hepatitis B and C, is the detection of serum or plasma viral load of these viruses for monitoring therapeutic responses of infected patients. Assays to quantify hep.....
    Document: Molecular techniques can be very useful for the diagnosis of viral hepatitis infections such as hepatitis A, B, C, D and E in cases in which serological assays are no conclusive. However, currently the main application of nucleic acid test in the management of these viruses, above all hepatitis B and C, is the detection of serum or plasma viral load of these viruses for monitoring therapeutic responses of infected patients. Assays to quantify hepatitis B and C virus load in liver tissue have also been described [83, 84] . HBV DNA detection and HBV DNA viral load are also essential to explore a viral reactivation. Real-time PCR quantification assays are widely used because of their sensitivity, specificity, accuracy, broad dynamic range and positive predictive values. The World Health Organization (WHO) has defined international standards [85] . However, because of these techniques do not use the same HBV primers, follow up of patients should be carried out with the same technical assay in order to compare viral DNA load evolution. With respect to the HBV genotypes, there is currently a need to perform it due to several factors such as the prediction of clinical outcomes and the association with response to interferon treatment [86] . Genotyping of chronic HBV infections can help practicing physicians identify those at risk of disease progression and determine optimal antiviral therapy. Methods to determine the viral genotypes are based on hybridization and sequencing, and genotype affiliation rely on phylogenetic analyses.

    Search related documents:
    Co phrase search for related documents
    • antiviral therapy and clinical outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral therapy and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral therapy and disease progression risk: 1, 2, 3, 4
    • antiviral therapy and dna detection: 1, 2, 3
    • antiviral therapy and dna load: 1
    • antiviral therapy and dynamic range: 1
    • antiviral therapy and HBV genotype: 1, 2
    • antiviral therapy and HBV infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • broad dynamic range and dynamic range: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • chronic HBV infection and clinical outcome: 1, 2, 3, 4
    • chronic HBV infection and disease progression: 1, 2, 3
    • chronic HBV infection and disease progression risk: 1
    • chronic HBV infection and dna detection: 1, 2
    • chronic HBV infection and dna load: 1
    • chronic HBV infection and dna viral load: 1
    • chronic HBV infection and HBV dna viral load: 1
    • chronic HBV infection and HBV genotype: 1, 2, 3
    • chronic HBV infection and HBV infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical outcome and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25